IBDEI07I ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3204,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3204,1,3,0)
 ;;=3^Genital Organ Inflammatory Disorder,Male,Unspec
 ;;^UTILITY(U,$J,358.3,3204,1,4,0)
 ;;=4^N49.9
 ;;^UTILITY(U,$J,358.3,3204,2)
 ;;=^5015749
 ;;^UTILITY(U,$J,358.3,3205,0)
 ;;=N50.9^^18^216^33
 ;;^UTILITY(U,$J,358.3,3205,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3205,1,3,0)
 ;;=3^Genital Organ Disorder,Male,Unspec
 ;;^UTILITY(U,$J,358.3,3205,1,4,0)
 ;;=4^N50.9
 ;;^UTILITY(U,$J,358.3,3205,2)
 ;;=^5015751
 ;;^UTILITY(U,$J,358.3,3206,0)
 ;;=N81.10^^18^216^23
 ;;^UTILITY(U,$J,358.3,3206,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3206,1,3,0)
 ;;=3^Cystocele,Unspec
 ;;^UTILITY(U,$J,358.3,3206,1,4,0)
 ;;=4^N81.10
 ;;^UTILITY(U,$J,358.3,3206,2)
 ;;=^5015838
 ;;^UTILITY(U,$J,358.3,3207,0)
 ;;=R39.9^^18^216^35
 ;;^UTILITY(U,$J,358.3,3207,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3207,1,3,0)
 ;;=3^Genitourinary System,Unspec Signs/Symptoms
 ;;^UTILITY(U,$J,358.3,3207,1,4,0)
 ;;=4^R39.9
 ;;^UTILITY(U,$J,358.3,3207,2)
 ;;=^5019351
 ;;^UTILITY(U,$J,358.3,3208,0)
 ;;=R31.9^^18^216^36
 ;;^UTILITY(U,$J,358.3,3208,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3208,1,3,0)
 ;;=3^Hematuria,Unspec
 ;;^UTILITY(U,$J,358.3,3208,1,4,0)
 ;;=4^R31.9
 ;;^UTILITY(U,$J,358.3,3208,2)
 ;;=^5019328
 ;;^UTILITY(U,$J,358.3,3209,0)
 ;;=R39.11^^18^216^37
 ;;^UTILITY(U,$J,358.3,3209,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3209,1,3,0)
 ;;=3^Hesitancy of Micturition
 ;;^UTILITY(U,$J,358.3,3209,1,4,0)
 ;;=4^R39.11
 ;;^UTILITY(U,$J,358.3,3209,2)
 ;;=^5019341
 ;;^UTILITY(U,$J,358.3,3210,0)
 ;;=N43.3^^18^216^38
 ;;^UTILITY(U,$J,358.3,3210,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3210,1,3,0)
 ;;=3^Hydrocele,Unspec
 ;;^UTILITY(U,$J,358.3,3210,1,4,0)
 ;;=4^N43.3
 ;;^UTILITY(U,$J,358.3,3210,2)
 ;;=^5015700
 ;;^UTILITY(U,$J,358.3,3211,0)
 ;;=N95.1^^18^216^39
 ;;^UTILITY(U,$J,358.3,3211,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3211,1,3,0)
 ;;=3^Menopausal & Female Climacteric States
 ;;^UTILITY(U,$J,358.3,3211,1,4,0)
 ;;=4^N95.1
 ;;^UTILITY(U,$J,358.3,3211,2)
 ;;=^5015927
 ;;^UTILITY(U,$J,358.3,3212,0)
 ;;=N95.9^^18^216^40
 ;;^UTILITY(U,$J,358.3,3212,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3212,1,3,0)
 ;;=3^Menopausal & Perimenopausal Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,3212,1,4,0)
 ;;=4^N95.9
 ;;^UTILITY(U,$J,358.3,3212,2)
 ;;=^5015929
 ;;^UTILITY(U,$J,358.3,3213,0)
 ;;=R35.1^^18^216^41
 ;;^UTILITY(U,$J,358.3,3213,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3213,1,3,0)
 ;;=3^Nocturia
 ;;^UTILITY(U,$J,358.3,3213,1,4,0)
 ;;=4^R35.1
 ;;^UTILITY(U,$J,358.3,3213,2)
 ;;=^5019335
 ;;^UTILITY(U,$J,358.3,3214,0)
 ;;=N45.2^^18^216^42
 ;;^UTILITY(U,$J,358.3,3214,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3214,1,3,0)
 ;;=3^Orchitis
 ;;^UTILITY(U,$J,358.3,3214,1,4,0)
 ;;=4^N45.2
 ;;^UTILITY(U,$J,358.3,3214,2)
 ;;=^86174
 ;;^UTILITY(U,$J,358.3,3215,0)
 ;;=N45.1^^18^216^28
 ;;^UTILITY(U,$J,358.3,3215,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3215,1,3,0)
 ;;=3^Epididymitis
 ;;^UTILITY(U,$J,358.3,3215,1,4,0)
 ;;=4^N45.1
 ;;^UTILITY(U,$J,358.3,3215,2)
 ;;=^41396
 ;;^UTILITY(U,$J,358.3,3216,0)
 ;;=R30.9^^18^216^43
 ;;^UTILITY(U,$J,358.3,3216,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3216,1,3,0)
 ;;=3^Painful Micturition,Unspec
 ;;^UTILITY(U,$J,358.3,3216,1,4,0)
 ;;=4^R30.9
 ;;^UTILITY(U,$J,358.3,3216,2)
 ;;=^5019324
 ;;^UTILITY(U,$J,358.3,3217,0)
 ;;=N73.9^^18^216^44
 ;;^UTILITY(U,$J,358.3,3217,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3217,1,3,0)
 ;;=3^Pelvic Inflammatory Disease,Female,Unspec
 ;;^UTILITY(U,$J,358.3,3217,1,4,0)
 ;;=4^N73.9
